Earlier studies have documented a crucial role of FOSL2 overexpression in metastatic cancer progression across multiple cancer subtypes owing to its influence on cell migration and proliferation [82,83,84]. The gene discussed is FOSL2; the disease is metastatic malignant neoplasm.